Quick Takeaways
- Philina Lee has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $2,104,740.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Philina Lee
- Location
- Hamilton, Bermuda
- Summary
- The estimated net worth of Philina Lee is at least $2,104,740 dollars as of 16 Apr 2026. Philina Lee is the Chief Commercial Officer of Blueprint Medicines Corp and owns shares of Blueprint Medicines Corp stock worth about $2.1M.
- Signature
- /s/ Virginie Boucinha, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Philina Lee and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Blueprint Medicines Corp ($2,104,740).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Philina Lee
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| BPMC | Blueprint Medicines Corp | Chief Commercial Officer | $2,104,740 | 17 Jul 2025 | ||
| DBVT, DBVTF | DBV Technologies S.A. | Director | 30 Oct 2025 | |||
| FUSN | Fusion Pharmaceuticals Inc. | Director | 04 Jun 2024 |
Insider Transactions Reported by Philina Lee:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.